What Does ‘Best Medical Therapy’ Really Mean?

1991, MRC European carotid surgery trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis, Lancet, 337, 1235, 10.1016/0140-6736(91)92916-P 1991, Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, N Engl J Med, 325, 445, 10.1056/NEJM199108153250701 Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, 1995, Endarterectomy for asymptomatic carotid stenosis, JAMA, 273, 1421, 10.1001/jama.1995.03520420037035 2004, Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial, Lancet, 363, 1491, 10.1016/S0140-6736(04)16146-1 Rothwell, 2004, Carotid Endarterectomy Trialists Collaboration: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery, Lancet, 363, 915, 10.1016/S0140-6736(04)15785-1 Rothwell, 2007, Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison, Lancet, 6, 953 Hennerici, 1987, Natural history of asymptomatic extracranial disease. Results of a long-term prospective study, Brain, 110, 777, 10.1093/brain/110.3.777 Sillesen, 2007, Stroke, 38, 457 2002, Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 CAPRIE Steering Committee, 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Diener, 1996, European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke, J Neurol Sci., 143, 1, 10.1016/S0022-510X(96)00308-5 Bhatt, 2006, for the CHARISMA investigators: Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events, N Engl J Med, 354 Nelson, 2005, Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70, BMJ, 330, 1306, 10.1136/bmj.38456.676806.8F The European Stroke Initiative Executive Committee and the EUSI Writing Committee, 2003, European stroke initiative recommendations for stroke management – update 2003, Cerebrovasc Dis, 16, 311, 10.1159/000072554 Amarenco, 2006, A placebo-controlled trial of high-dose atorvastatin in patients with recent stroke or transient ischemic attack. The Stroke Prevention with Aggressive Reduction in Cholesterol Levels (SPARCL) Study, New England Journal of Medicine, 355, 549 Schwartz, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 1 LaRosa, 2005, Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N Engl J Med., 352, 1425, 10.1056/NEJMoa050461 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Pedersen, 2005, High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial, JAMA, 294, 2437, 10.1001/jama.294.19.2437 European Society for Hypertension The Heart Outcomes Prevention Evaluation Study Investigators, 2000, Effects of an angiotensin converting enzyme inhibitor, Ramipril, on cardiovascular events in high risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Östergren, 2004, Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease, European Heart Journal, 25, 17, 10.1016/j.ehj.2003.10.033 Dahlöf, 2002, Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3 International diabetes federation guidelines to treatment of diabetes <www.idf.org> Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med, 348, 383, 10.1056/NEJMoa021778 Sillesen, 2007, Organising a nurse-driven PAD rehabilitation clinic within the vascular surgical department: what is required and are treatment goals reached – a prospective study?, Eur J Vasc Endovasc Surg, 33, 26, 10.1016/j.ejvs.2006.07.022